277 related articles for article (PubMed ID: 8725391)
21. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Coca A; Giner V
Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
Triggle DJ
Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II receptor inhibition. A new therapeutic principle.
Messerli FH; Weber MA; Brunner HR
Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
[TBL] [Abstract][Full Text] [Related]
24. The advantages of angiotensin II antagonism.
Burnier M; Waeber B; Brunner HR
J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
[TBL] [Abstract][Full Text] [Related]
25. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
26. New angiotensin-II blocker.
Lilley LL; Guanci R
Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
[No Abstract] [Full Text] [Related]
27. Angiotensin receptors: physiology and pharmacology.
Guthrie GP
Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
[TBL] [Abstract][Full Text] [Related]
28. Human angiotensin receptor subtypes.
Smith RD; Timmermans PB
Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):112-22. PubMed ID: 7850406
[TBL] [Abstract][Full Text] [Related]
29. The role of angiotensin II receptors and their antagonists in hypertension.
van Zwieten PA
Ann Ital Med Int; 2000; 15(1):85-91. PubMed ID: 10842896
[TBL] [Abstract][Full Text] [Related]
30. A new class of therapeutic agents: the angiotensin II receptor antagonists.
Timmermans PB; Smith RD
Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
[TBL] [Abstract][Full Text] [Related]
31. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
32. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation.
Oliverio MI; Best CF; Kim HS; Arendshorst WJ; Smithies O; Coffman TM
Am J Physiol; 1997 Apr; 272(4 Pt 2):F515-20. PubMed ID: 9140053
[TBL] [Abstract][Full Text] [Related]
34. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
[TBL] [Abstract][Full Text] [Related]
35. Losartan: the first angiotensin receptor antagonist in clinical use.
Beevers DG
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
[No Abstract] [Full Text] [Related]
36. [Angiotensin II antagonists: a distinct therapeutic class].
Waeber B; Brunner HR
Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
[TBL] [Abstract][Full Text] [Related]
37. AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
Jalowy A; Schulz R; Heusch G
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S129-36. PubMed ID: 9892153
[TBL] [Abstract][Full Text] [Related]
38. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
Waeber B; Nussberger J; Brunner H
Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114
[No Abstract] [Full Text] [Related]
39. Molecular biology of angiotensin receptors: target for drug research?
Dzau VJ; Mukoyama M; Pratt RE
J Hypertens Suppl; 1994 Jul; 12(2):S1-5. PubMed ID: 7965260
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Schmidt B; Schieffer B
J Med Chem; 2003 Jun; 46(12):2261-70. PubMed ID: 12773029
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]